Armstrong Fleming & Moore’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Buy
13,950
+1,370
+11% +$319K 1.45% 10
2025
Q4
$2.6M Buy
12,580
+7
+0.1% +$1.38K 1.2% 15
2025
Q3
$2.33M Sell
12,573
-15
-0.1% -$2.57K 1.11% 17
2025
Q2
$1.92M Buy
12,588
+8,673
+222% +$1.33M 1.04% 16
2025
Q1
$649K Sell
3,915
-8,366
-68% -$1.31M 0.79% 29
2024
Q4
$1.78M Sell
12,281
-191
-2% -$29.6K 1.08% 21
2024
Q3
$2.02M Sell
12,472
-857
-6% -$137K 1.18% 17
2024
Q2
$1.95M Sell
13,329
-17
-0.1% -$2.53K 1.25% 18
2024
Q1
$2.11M Sell
13,346
-1,298
-9% -$207K 1.46% 12
2023
Q4
$2.3M Sell
14,644
-67
-0.5% -$10.3K 1.73% 8
2023
Q3
$2.29M Sell
14,711
-414
-3% -$68.3K 2.22% 9
2023
Q2
$2.5M Buy
+15,125
New +$2.44M 2.3% 7

Other funds holding JNJ

Armstrong Fleming & Moore's JNJ Position: Q1 2026 in Review

Armstrong Fleming & Moore increased its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, buying an estimated $319K and bringing the position to 13,950 shares worth $3.41M. The position accounts for 1.45% of the portfolio, ranked #10.

Armstrong Fleming & Moore first reported a position in JNJ in Q2 2023 and has held it in 12 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Armstrong Fleming & Moore held 13,950 shares of Johnson & Johnson worth $3.41M as of Q1 2026.
  • Armstrong Fleming & Moore bought 1,370 Johnson & Johnson shares in Q1 2026, an estimated $319K.
  • Johnson & Johnson made up 1.45% of Armstrong Fleming & Moore's portfolio in Q1 2026, its #10 holding.
  • Armstrong Fleming & Moore first reported a position in Johnson & Johnson in Q2 2023 and has held it in 12 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Armstrong Fleming & Moore's 13F filing for Q1 2026, filed 13 Apr 2026.